KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Non Operating Income: 2015-2019

Historic Other Non Operating Income for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Dec 2019 value amounting to -$41.1 million.

  • Aurinia Pharmaceuticals' Other Non Operating Income fell 157.60% to -$2.6 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$57.5 million, marking a year-over-year decrease of 2840.96%. This contributed to the annual value of -$41.1 million for FY2019, which is 313.14% down from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Other Non Operating Income stood at -$41.1 million for FY2019, which was down 313.14% from -$10.0 million recorded in FY2018.
  • In the past 5 years, Aurinia Pharmaceuticals' Other Non Operating Income ranged from a high of $1.7 million in FY2016 and a low of -$41.1 million during FY2019.
  • For the 3-year period, Aurinia Pharmaceuticals' Other Non Operating Income averaged around -$25.0 million, with its median value being -$23.9 million (2017).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first spiked by 133.95% in 2016, then slumped by 1,481.29% in 2017.
  • Yearly analysis of 5 years shows Aurinia Pharmaceuticals' Other Non Operating Income stood at -$5.1 million in 2015, then skyrocketed by 133.95% to $1.7 million in 2016, then crashed by 1,481.29% to -$23.9 million in 2017, then spiked by 58.39% to -$10.0 million in 2018, then crashed by 313.14% to -$41.1 million in 2019.